Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-09-22-Speech-3-215"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20100922.20.3-215"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
"The fact that we abstained at first reading shows our concern about certain critical issues that a majority in this House has ignored, in view of the real need for the Member States to protect their citizens against the harmful effects on health and the environment of the active biocidal substances that are used on the market.
The European Chemicals Agency, which will be responsible for scientifically evaluating whether the use of a biocide on the market can be authorised, will now have three months to prepare an opinion based on the conclusions of the evaluation and to submit it to the Commission, instead of the nine months previously proposed. We do not believe that this reduction will benefit the rigorous approach needed to protect public health and the environment. We hope this issue can be reconsidered yet again in future negotiations with the Commission and the Council.
We are pleased with the acknowledgment that the Member States will be able to take account of regional differences and local environmental issues in their national authorisations, and also with the reference to respect for the principle of subsidiarity. We also welcome the proposed procedures for nanomaterials and the added levels of protection to be considered in the case of more vulnerable groups, such as children and pregnant women."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples